Articles

1. The role of community pharmacists and pharmacies in physical activity promotion: an interdisciplinary e-Delphi study

   • Ruben Viegas
   • Mara Pereira Guerreiro
   • Filipa Alves da Costa

   Research Article Open access 25 April 2024

2. Intraclass comparison of inhaled corticosteroids for the risk of pneumonia in chronic obstructive pulmonary airway disorder: a network meta-analysis and meta-regression

   • Kannan Sridharan
   • Gowri Sivaramakrishnan

   Review Article 25 April 2024

   

3. Delabeling of allergy to beta-lactam antibiotics in hospitalized patients: a prospective study evaluating cost savings

   • Miriam Sobrino-García
   • Francisco J. Muñoz-Bellido
   • Ignacio Dávila

   Research Article 20 April 2024

   

4. Cost-effectiveness analysis of fruquintinib in Chinese patients with refractory metastatic colorectal cancer

   • Zijia Huang
   • Lingyan Zhou
   • Mei Zhan

   Research Article 20 April 2024

   

5. Clinical impact of an individualised clinical pharmacy programme into the memory care pathway of older people: an observational study

   • Teddy Novais
   • Elsa Reallon
   • Christelle Mouchoux

   Research Article 20 April 2024

   

6. Exploring the impact of anticholinergic burden on urinary independence: insights from a post-stroke cohort of older adults

   • Ayaka Matsumoto
   • Yoshihiro Yoshimura
   • Kenichiro Maekawa

   Research Article 18 April 2024

   

7. Assessing feasibility of conducting medication review with follow-up among older adults at community pharmacy: a pilot randomised controlled trial

   • Christina Malini Christopher
   • Ali Qais Blebil
   • Mark Wing Loong Cheong

   Research Article Open access 18 April 2024

   

8. Author Correction: Assessing safety concerns of interstitial lung disease associated with antibody-drug conjugates: a real-world pharmacovigilance evaluation of the FDA adverse event reporting system

   • Wanlong Lin
   • Jiabing Xu
   • Wei Zhuang

   Author Correction 17 April 2024

9. Adverse events of nivolumab plus ipilimumab versus nivolumab plus cabozantinib: a real-world pharmacovigilance study

   • Yurie Oka
   • Jun Matsumoto
   • Noritaka Ariyoshi

   Short Research Report 17 April 2024

   

10. A systematic review of the impact of simulation on students’ confidence in performing clinical pharmacy activities

    • Jean-François Huon
    • Pierre Nizet
    • Fabien Nativel

    Review Article 17 April 2024

    

11. Novel opportunities for clinical pharmacy research: development of a machine learning model to identify medication related causes of delirium in different patient groups

    • Anita Elaine Weidmann
    • Edward William Watson

    Commentary Open access 09 April 2024

    

12. An umbrella review of the diagnostic value of next-generation sequencing in infectious diseases

    • Hong Cao
    • Yan Chen
    • Jiaxing Zhang

    Review Article 03 April 2024

    

13. Clinical pharmacy key performance indicators for hospital inpatient setting: a systematic review

    • Lucas Magedanz
    • Hiolanda Lêdo Silva
    • Fernando Fernandez-Llimos

    Review Article Open access 03 April 2024

    

14. Critical care pharmacy service provision and workforce in adult extracorporeal membrane oxygenation centres: a multicentre cross-sectional survey

    • Christopher Remmington
    • Lynda Cameron
    • Cathrine McKenzie

    Research Article 29 March 2024

    

15. Clinical risk assessment of modelled situations in a pharmaceutical decision support system: a modified e-Delphi exploratory study

    • Juline Bouet
    • Arnaud Potier
    • Édith Dufay

    Research Article 29 March 2024

    

16. Community pharmacists’ views and experiences of delivering in-pharmacy medication reviews for people living with severe and persistent mental illness: a qualitative study

    • Ricki Ng
    • Sarira El-Den
    • Claire L. O’Reilly

    Research Article Open access 29 March 2024

17. Polypharmacy and medication regimen complexity in transfusion-dependent thalassaemia patients: a cross- sectional study

    • Geok Ying Chun
    • Sharon Shi Min Ng
    • Nurul Ain Mohd Tahir

    Research Article 29 March 2024

    

18. The efficacy of zuranolone versus placebo in postpartum depression and major depressive disorder: a systematic review and meta-analysis

    • Mackenzie Winslow
    • Emily White
    • Eric C. Nemec II

    Review Article 15 March 2024

    

19. Implementation of medication reviews in community pharmacy: reaching consensus on stakeholders’ recommendations for mechanisms of change using the nominal group technique

    • Dorothee E. Michel
    • Antonella P. Tonna
    • Anita E. Weidmann

    Research Article Open access 15 March 2024

    

20. European Society of Clinical Pharmacy: ‘Implementing and scaling sustainable clinical pharmacy’

    • Michael Scott
    • Kamila Urbańczyk
    • Derek Stewart

    Editorial 13 March 2024 Pages: 355 - 356

21. A qualitative study exploring the challenges and enablers of pharmacists with a recent background in community pharmacy transitioning into primary care

    • Ian Campbell
    • Heather Harrison
    • Amanj Kurdi

    Research Article 13 March 2024

    

22. Artificial intelligence in academic writing and clinical pharmacy education: consequences and opportunities

    • Anita Elaine Weidmann

    Commentary Open access 12 March 2024

23. Availability, price, and affordability of anti-hepatitis B virus drugs: a cross-sectional study in China

    • Yue Li
    • Mengdie Zhang
    • Tao Lu

    Research Article 12 March 2024

    

24. Correction: Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical Pharmacy

    • Francesca Wirth
    • Cathal A. Cadogan
    • Martin C. Henman

    Correction Open access 02 March 2024 Pages: 558 - 558

25. Unveiling the future: precision pharmacovigilance in the era of personalized medicine

    • Lurdes Silva
    • Teresa Pacheco
    • Renato Ferreira-da-Silva

    Commentary Open access 28 February 2024

26. A case–control study on the clinical characteristics of granisetron-related arrhythmias and the development of a predictive nomogram

    • Peng Li
    • Man Zhu
    • Daihong Guo

    Research Article 28 February 2024

    

27. Cost-effectiveness analysis of PD-1 inhibitors as second-line therapy for advanced or metastatic esophageal squamous cell carcinoma in China: an economic evaluation based on network meta-analysis

    • Shuang Liu
    • Linbo Zhao
    • Jianhua Tang

    Research Article 26 February 2024

    

28. Pharmaceutical care for visually impaired patients: a qualitative study of community pharmacists' needs and professional experience

    • Théodora Merenda
    • Jennifer Denis
    • Stéphanie Patris

    Research Article 26 February 2024

    

29. A cohort study comparing pharmacist activities during participation in general medical ward rounds: telehealth versus in-person during the COVID-19 pandemic

    • Meng Yap
    • Gail Edwards
    • Erica Y. Tong

    Research Article 17 February 2024 Pages: 522 - 528

30. Antipsychotic prescribing and drug-related readmissions in multimorbid older inpatients: a post-hoc analysis of the OPERAM population

    • A. Bienfait
    • J. Lagreula
    • O. Dalleur

    Research Article 17 February 2024

    

31. A cross-sectional survey of viral hepatitis education within pharmacy curricula in the United States

    • Michelle T. Martin
    • Aileen N. Pham
    • Jessica S. Wagner

    Research Article 14 February 2024

    

32. Intervention for a correct medication list and medication use in older adults: a non-randomised feasibility study among inpatients and residents during care transitions

    • Ahmed Al Musawi
    • Lina Hellström
    • Tommy Eriksson

    Research Article Open access 10 February 2024

    

33. Writing a manuscript for publication in a peer-reviewed scientific journal: Guidance from the European Society of Clinical Pharmacy

    • Francesca Wirth
    • Cathal A. Cadogan
    • Martin C. Henman

    Commentary Open access 08 February 2024 Pages: 548 - 554

34. Whole blood thiamine, intravenous thiamine supplementation and delirium occurrence in the intensive care unit: retrospective cohort analyses

    • Muhammad A. Mumin
    • Cathrine A. McKenzie
    • Peter E. Spronk

    Research Article 08 February 2024

35. First generation antipsychotic-associated serious adverse events in women: a retrospective analysis of a pharmacovigilance database

    • Kenneth L. McCall
    • Bennett J. Doughty
    • Emily E. Leppien

    Research Article 05 February 2024 Pages: 515 - 521

    

36. Pharmacists working in residential aged care: a survey of pharmacist interest and perceived preparedness

    • Amanda J. Cross
    • Deborah Hawthorne
    • Amy Theresa Page

    Research Article Open access 05 February 2024 Pages: 506 - 514

    

37. Financial impact of medication reviews by clinical pharmacists to reduce in-hospital adverse drug events: a return-on-investment analysis

    • Mégane Jermini
    • Caroline Fonzo-Christe
    • Bertrand Guignard

    Research Article Open access 05 February 2024 Pages: 496 - 505

    

38. Effects of inpatient creatinine testing frequency on acute kidney injury identification and staging: a historical cohort study

    • Catarina Luz Oliveira
    • Filipa Duarte-Ramos
    • Fernando Fernandez-Llimos

    Research Article Open access 05 February 2024

    

39. Correction: The effectiveness and safety of bevacizumab versus cetuximab in the treatment of colorectal cancer: a systematic review and meta‑analysis

    • Yuying Cui
    • Yingxue Guo

    Correction 25 January 2024 Pages: 555 - 557

    

40. Abstracts of the 27th Annual Meeting of ESPACOMP, the International Society for Medication Adherence, Budapest, Hungary, 30 November–1 December 2023

    Conference Abstracts 25 January 2024 Pages: 328 - 353

41. Psychiatric adverse events associated with semaglutide, liraglutide and tirzepatide: a pharmacovigilance analysis of individual case safety reports submitted to the EudraVigilance database

    • Mansour Tobaiqy
    • Hajer Elkout

    Research Article Open access 24 January 2024 Pages: 488 - 495

    

42. Exploring the safety profile of tremelimumab: an analysis of the FDA adverse event reporting system

    • Yibei Zhao
    • Huiming Jiang
    • Long Meng

    Research Article 20 January 2024 Pages: 480 - 487

    

43. Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database

    • Sha Zhang
    • Yidong Wang
    • Deqiu Zhu

    Research Article 20 January 2024 Pages: 471 - 479

    

44. A comparison between the adverse event profiles of patients receiving palbociclib and abemaciclib: analysis of two real-world databases

    • Tatsuaki Takeda
    • Shiho Sugimoto
    • Yoshito Zamami

    Short Research Report 19 January 2024 Pages: 536 - 541

    

45. Comparison of the sensitivities of pharmacotherapy-related and disease-specific quality of life measures in response to pharmacist-led pharmaceutical care for cancer outpatients: a randomised controlled trial

    • Phantipa Sakthong
    • Porntip Soipitak
    • Win Winit-Watjana

    Research Article 19 January 2024 Pages: 463 - 470

    

46. Defining quality indicators, pharmaceutical care bundles and outcomes of clinical pharmacy service delivery using a Delphi consensus approach

    • Martin Luke Canning
    • Michael Barras
    • Karen Whitfield

    Research Article 19 January 2024 Pages: 451 - 462

47. Thank you from the Editor-in-Chief

    Acknowledgment 19 January 2024 Pages: 1 - 3

48. Communication skills-based training about medication switch encounters: pharmacy staff and patients’ experiences

    • Laura Schackmann
    • Ellen S. Koster
    • Mette Heringa

    Research Article 17 January 2024 Pages: 439 - 450

    

49. 51st ESCP symposium on clinical pharmacy 31 October–02 November 2023, Aberdeen, Scotland

    Abstract 09 January 2024 Pages: 214 - 327

50. Barriers to person-centered service design in pharmacy practice: examples, lessons, and potential solutions

    • Logan T. Murry
    • Shane P. Desselle

    Commentary 09 January 2024 Pages: 542 - 547